This session brings together leaders from pharma, AI technology, life sciences platforms, CROs, and specialized biotech AI to cut through the noise and examine how artificial intelligence is delivering tangible value in biopharma today. Panelists will explore the evolution from AI pilots to scaled implementation, sharing concrete examples of where AI is meaningfully accelerating drug discovery, improving R&D productivity, and enabling new scientific approaches. The discussion will address current technical and organizational challenges, practical strategies for integrating AI into existing workflows, and near-future developments that will further transform the industry. Attendees will gain actionable insights into building effective AI capabilities, measuring ROI on AI investments, and preparing their organizations for the next wave of AI-powered innovation in biopharma.